The Doxycycline Tablets, with their unique blend of active ingredients, are designed to support your Lyme disease treatment. These Doxycycline Tablets are not suitable for use in individuals with a known or suspected pre-existing kidney or liver disease, especially if they are taking other medications.
Symptoms of Lyme disease include:
Doxycycline Tablets contain:
The capsules are coated and therefore protect the contents of the tube from light. Keep the capsules from drying and for the dosing device to take place during the day.
The capsules are packed in a single pack thus providing effective support for treatment and for easy administration.
Avoid consuming alcohol while taking Doxycycline Tablets, as it may reduce its effectiveness.
Do not drink grapefruit juice while taking Doxycycline Tablets, as it may decrease its anti-inflammatory action.
The capsules can be used in patients who do not respond to previous oral anticoagulants or who are intolerant to chlorthalidone.
Avoid taking Doxycycline Tablets with grapefruit juice, as it may reduce its anti-inflammatory action.
Use of the Doxycycline Tablets may cause nausea, vomiting, and diarrhoea. If these effects are experienced, stop taking the medication and contact your doctor.
Avoid consuming alcohol while taking Doxycycline Tablets, as it may reduce its anti-inflammatory action.
Methadone can increase the levels of the drug in the blood, which can lead to serious blood disorders.
Methadone can increase the levels of the drug in the blood, which can lead to serious blood disorders, including thrombosis (blood clots) and embolization (clotting of blood).
If you experience any of these symptoms, stop taking the medication and contact your doctor immediately.
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding before taking Doxycycline Tablets.
Doxycycline Tablets with a black pigmentDo not take Doxycycline Tablets with any dairy products, antacids, calcium supplements, iron, antacids, calcium supplements, aluminum or calcium phosphate binders (calcium antacids, aluminum hydroxide antacids, magnesium hydroxide antacids, calcium hydrogen phosphate antacids, magnesium hydroxide, iron or calcium antacids), or zinc supplements. Doxycycline Tablets can have an impact on the absorption of the drug and may affect the way other medicines do so.
This product contains a pigment called Doxycycline. It is not specifically indicated for people with a known allergies to Doxycycline or any other ingredients in the product. Doxycycline Tablets with a black pigment are generally not suitable for individuals with a known allergies to these ingredients.
Please read the enclosed leaflet carefully before use.
General Product DescriptionDoxycycline Hydrochloride is used to treat a wide variety of bacterial infections in dogs and cats. This medicine works by killing or stopping the growth of bacteria. Doxycycline Hydrochloride is available in tablets, capsules, and liquid suspensions. Dogs and cats usually take this medicine every 6 hours or 30 minutes. It is not recommended to give this medicine to other pets in the same group. If your pet has a prolonged QT interval, monitor your veterinarian for cardiac issues, tremors, and seizures. This medicine may cause temporary or permanent decrease in blood pressure and heart rate. Before giving this medicine to you or your pet, tell your veterinarian if you are allergic to it, or if you have any other allergies. This medicine may also cause diarrhea, vomiting, or allergic reactions. Tell your veterinarian if your pet has diarrhea that is similar to the diarrhea that a pet with QT prolongation may experience. If you suspect that your pet has diarrhea that is similar to the diarrhea that a pet with QT prolongation may experience, do not use this medicine. Monitor and treat your pet with this medicine if needed. Not suitable for use in animals with hepatic, renal, or heart disease. This medicine may cause vomiting, diarrhea, diarrhea with or without respiratory tract infection, fever, swollen lymph nodes, increased heart rate, or vomiting. Tell your veterinarian if your pet has vomiting that is similar to the vomiting that a pet with QT prolongation may experience or diarrhea that is similar to the diarrhea that a pet with QT prolongation may experience. Do not give this medicine to others. Do not use this medicine to treat a viral or fungal infection in your pet. This medicine may cause diarrhea, vomiting, vomiting, vomiting, diarrhea, vomiting, skin rashes, and pet's skin reddening or puffying the eye. Wash your pet's hands after giving the product to them. Wash your pet's hands with soap and water, and give this medicine to them after the product has been given. This medicine can be given to your pet at any time of the day. Do not give this medicine to your pet during the day. Wash your pet's hands after the medicine has left their original contact lenses. Do not use this medicine if they are not having trouble with the urine. Using your pet for longer than directed can cause some of the symptoms of a viral infection such as blisters or ulcers that may occur after treatment has been started. When giving this medicine to your pet, follow the dosing instructions provided by your veterinarian. Do not give this medicine to pet that is pregnant or nursing. Doxycycline Hydrochloride can cause some skin rash and blisters that may be the sign of a new infection. Be sure to use a clean, dry, well-lit area, such as between the eyelids or nose, in which to use the medicine. Do not use it in the eye, on the neck, or on the top of the head. Do not apply the medicine to your pet's skin. If you use this medicine to treat a skin infection, do not use it. This medicine may cause skin rash and blisters that may be the sign of a new infection. Be sure to use a clean, dry, well-lit area, such as between the skin and the underarm of the neck or the underarms of the neck or the underarms of the neck or the underarms of the ears. If you use this medicine to treat a skin infection, use only the skin that is treated for your pet's skin. Wash your pet's hands after using the product. Do not use this medicine if you are having trouble with urine or feces. If you are using this medicine to treat a skin infection, do not use it. Ask your veterinarian what to do if you do not have a good skin infection. Ask your veterinarian to perform skin biopsy to see how your pet is affected. If your pet is not having trouble with urine, or if urticaria or wheeze is not being seen, do not use this medicine. If the skin is not getting better, your pet's skin may turn yellow. Do not give this medicine to your pet. If your pet is having trouble with urine or feces, call your veterinarian or pharmacist. If you need to use this medicine to treat a skin infection, you may use it for longer than advised. The duration of treatment depends on the type and severity of the infection. For viral infections (such as the common cold or flu), treatment may last for a few days or weeks. For a longer infection (such as more severe conditions like liver or kidney disease), treatment may be needed. For a more severe infection (such as a serious skin infection that requires surgery or a life-threatening allergic reaction), treatment may need to be continued for the longer duration of treatment.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Common Brand Name(s): CLAY
SKUdoxycycline-hyclate-10-MG-Oral-Tablet
This medication is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and eye infections. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections such as the common cold.
Nausea, diarrhea, sunlight sensitivity may occur. If any of these or other symptoms worsen, or worsen as the benefits outweigh the risks, tell your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if you have any serious side effects, including: dark urine, persistent nausea/vomiting, signs of a new infection (such as fever, persistent sore throat, persistent sore throat), signs of kidney problems (such as change in the amount of urine, change in the amount of water, pain in the lower stomach/abdominal pain), signs of liver problems (such as severe persistent bleeding, yellowing of the skin or eyes, dark urine), signs of jaundice (with the use of any kind of doctor'spictured drug), signs of kidney problems (such as change in the amount of urine, change in the amount of water, pain in the lower stomach/abdominal pain/other symptoms of jaundice). A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
This document is subject to changeto include a bigger list of possible side effects, as well as more severe side effects. You may be able to report side effects by contacting health information for your telephone number (via the dialing method listed at the end of this document). If you are unable to call/text the affected party, call your doctor or pharmacist first. US citizens can report side effects by first calling 1-800-FDA-1088. In the UK the Fda has changed its side effect list to include a bigger variety of side effects. You may be able to report side effects by phone or mail. In the USA or Europe - Call 1-866-234-2345 to report side effects. You may report side effects by emailing or dialing a toll-free number (via e-mail, SMS, or dialing a live chat box). In the UK toll-free number (via e-mail, SMS, or dialing a live chat box) - 1-866-234-2345.
If you are unable to read or speak a language other than your will, you may be able to use one of the provided resources to speak a language other than your will. For example, you may be able to use a language other than your will for which you may be unable to speak. However, you may not be able to use the provided resources to speak a specific language. If you are unable to speak a specific language, you may be able to use the provided resources to speak it in that language. For example, in the USA you may be able to use a language that you cannot speak in your will. In the UK you may be able to speak a language other than your will if you use the internet and the language resources listed below are also available:
For additional information, please see the "How do I get an online prescription from my doctor?" section of the patient information leaflets or in the patient information manual (Patient Information Leaflets US, 2023,currentained by the American College of Pharmacy).
Patel R, Geddes C. Tetracycline antibiotic. A controlled trial.Acta dermatográfica2018;34(4):4–9.
Patel K, Jonsson M, O’Donnell P, et al. (2010).20th edition. Elsevier/Bristol. Copyright © 2010 Elsevier/Bristol. All rights reserved.
Dingley M, Cauwels M, Mazzuca A, et al. (2015).Antibiotic-associated infection in children: risk factors for and prevention strategies.Clin Infect Dis20(1):21–33.
Foster L, Kontogian F. Doxycycline, ampicillin and amoxicillin. (2022).Biol Infect Dis2022;15:1–4.
Gordet JL, Luye P.Tetracycline antibiotic resistance in the United States: recent trends, recent trends, and future guidelines.Ann Intern Med2022;147(8):1875–83.
Hsu JL, Li X, Li Y, et al. (2017).J Am Gen Assoc Dis22(1):36–44.
Wang Y, Liu J, Liu Y, et al.
Baumgartner J, Bauch H, Gebard H, et al. (2021).22(1):37–46.
Zheng W, Yang Y, Yang Y, et al.
Yuan H, Zhang L, Li H, et al.
Razenda A, Nastas H, Rangaraj P, et al.
Koh J, Kim S, Jeong J, et al.